Evidence map›Paper›PMID 12417626›Full record

ArticleThe Journal of experimental medicine2002

Reduced self-reactivity of an autoreactive T cell after activation with cross-reactive non-self-ligand.

Markus Munder, Estelle Bettelli, Laurent Monney, Jacqueline M Slavik, Lindsay B Nicholson, Vijay K Kuchroo

Abstract read
In one paragraph

Article in The Journal of experimental medicine, 2002. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Manipulating antigenic ligand strength to selectively target myelin-reactive CD4+ T cells in EAE.Journal of neuroimmune pharmacology : the official journal of the Society on NeuroImmune Pharmacology · 2010
    Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Killers come to the rescue.Nature biotechnology · 2002
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Markus MunderCenter for Neurologic Diseases, Brigham and Women's Hospital and Harvard Medical School, Boston, MA 02115, USA.
Estelle Bettelli
Laurent Monney
Jacqueline M Slavik
Lindsay B Nicholson
Vijay K Kuchroo

Funding

Role of Negative Costimulation in Regulation of AutoimmunityP01AI039671 · NIAID · YALE UNIVERSITY · PI David A. Hafler · 1996 to 2026
$51.7M
The function of T Bet in EAEP01NS038037 · NINDS · BRIGHAM AND WOMEN'S HOSPITAL · PI KUCHROO, VIJAY K. · 2000 to 2010
$12.8M
T CELL RESPONSE TO MYELIN PROTEOLIPID PROTEINR01NS030843 · NINDS · BRIGHAM AND WOMEN'S HOSPITAL · PI KUCHROO, VIJAY K. · 1998 to 2019
$4.1M
Role of costimulation in induction and regulation of EAER01NS035685 · NINDS · BRIGHAM AND WOMEN'S HOSPITAL · PI KUCHROO, VIJAY K. · 1996 to 2012
$3.8M
REGULATION OF AUTOREACTIVE T CELLS BY ALTERED PEPTIDESK08AI001557 · NIAID · BRIGHAM AND WOMEN'S HOSPITAL · PI NICHOLSON, LINDSAY B · 1998 to 2000
$129k
NIAID NIH HHS K08 AI01557-01NIAID NIH HHS P01 AI039671NIAID NIH HHS P01AI39671-01A1NINDS NIH HHS P01 NS038037NINDS NIH HHS P01NS38037-01A1NINDS NIH HHS R01 NS030843NINDS NIH HHS R01 NS035685NINDS NIH HHS R01NS30843NINDS NIH HHS R01NS35685
6 · The paper itself

Abstract

Autoreactive CD4(+) T lymphocytes are critical to the induction of autoimmune disease, but because of the degenerate nature of T cell receptor (TCR) activation such receptors also respond to other ligands. Interaction of autoreactive T cells with other non-self-ligands has been shown to activate and expand self-reactive cells and induce autoimmunity. To understand the effect on the autoreactivity of naive cross-reactive T cells of activation with a potent nonself ligand, we have generated a TCR transgenic mouse which expresses a TCR with a broad cross-reactivity to a number of ligands including self-antigen. The activation of naive transgenic recombination activating gene (Rag)2(-)(/)(-) T cells with a potent non-self-ligand did not result in a enhancement of reactivity to self, but made these T cells nonresponsive to the self-ligand and anti-CD3, although they retained a degree of responsiveness to the non-self-ligand. These desensitized cells had many characteristics of anergic T cells. Interleukin (IL)-2 production was selectively reduced compared with interferon (IFN)-gamma. p21(ras) activity was reduced and p38 mitogen-activated protein kinase (MAPK) was relatively spared, consistent with known biochemical characteristics of anergy. Surprisingly, calcium fluxes were also affected and the anergic phenotype could not be reversed by exogenous IL-2. Therefore, activation with a hyperstimulating non-self-ligand changes functional specificity of an autoreactive T cell without altering the TCR. This mechanism may preserve the useful reactivity of peripheral T cells to foreign antigen while eliminating responses to self.

Indexed as

CD3 ComplexAmino Acid SequenceAnimalsCalciumCD4-Positive T-LymphocytesCross ReactionsFemaleJNK Mitogen-Activated Protein KinasesLigandsLymphocyte ActivationMembrane ProteinsMiceMice, TransgenicMitogen-Activated Protein Kinase 1Mitogen-Activated Protein Kinase 3Mitogen-Activated Protein Kinasesantigen T cell receptor, zeta chainCalciumCD3 ComplexCD3E protein, humanJNK Mitogen-Activated Protein KinasesLigandsMembrane ProteinsMitogen-Activated Protein Kinase 1Mitogen-Activated Protein Kinase 3Mitogen-Activated Protein KinasesProtein-Tyrosine KinasesProto-Oncogene Proteins p21(ras)Receptors, Antigen, T-CellZap70 protein, mouseZAP-70 Protein-Tyrosine Kinase

Identifiers

PMID12417626
PMCPMC2194103

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.